Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. (2022)
Attributed to:
The Role of Complement Component C1Q in Tuberculosis and Diabetes Co-morbidity
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104173
PubMed Identifier: 35841871
Publication URI: http://europepmc.org/abstract/MED/35841871
Type: Journal Article/Review
Volume: 82
Parent Publication: EBioMedicine
ISSN: 2352-3964